Community pharmacies push for bigger share of obesity care
Community pharmacists want a greater role in obesity care, according to commentary published by Chemist+Druggist. Consultant pharmacist Hannah Beba said pharmacies should be used more to help prevent obesity, pointing to day-to-day primary care work and weight management medication delivery as areas where the sector could contribute more.
What happened
Speaking to Chemist+Druggist, Hannah Beba — a consultant pharmacist — argued that community pharmacies are "very keen" to expand their involvement in obesity care and that they are currently underused in this area. Her central point: "pharmacies should be greater utilised to help prevent obesity."
Beba identified two broad areas where pharmacies could take on more work. First, routine primary care tasks that currently sit elsewhere in the system. Second, involvement in delivering weight management medications to patients. The comments reflect a broader conversation happening across community pharmacy about how the sector positions itself as pressures on GP surgeries and secondary care continue to build.
Why it matters
Obesity is one of the most significant public health challenges the NHS is dealing with right now. GP waiting times remain long, and the number of patients seeking weight management support has grown sharply in recent years, partly driven by wider public awareness of injectable weight loss medications. That demand has to go somewhere, and pharmacists — who are already accessible without an appointment and have clinical training — are making the case that they should absorb more of it.
For pre-registration trainees, this conversation matters for a few reasons.
First, it shapes the kind of work you might actually be doing within the next few years. If community pharmacy does secure a more formal role in obesity care, that could mean structured services involving lifestyle counselling, medication reviews, and patient monitoring. These are areas where pharmacist-led consultations are a natural fit, and where the skills you are building now — taking a medication history, identifying contraindications, communicating clearly with patients about complex conditions — will apply directly.
Second, the debate around pharmacy's role in weight management touches on questions of professional scope that come up in the GPhC's own standards. Pharmacists are expected to recognise when they can act and when they need to refer. In a condition like obesity, where treatment options range from behavioural interventions to prescription medications with specific eligibility criteria, that clinical judgement matters a lot. Knowing where pharmacy fits — and where it doesn't — is part of being a competent practitioner.
Third, this is a careers story. Community pharmacy has faced sustained pressure on funding and workforce, and services like obesity care represent one of the clearest arguments for investing in the sector. The more pharmacy demonstrates clinical value in managing long-term conditions, the stronger the case for pharmacist roles that go beyond dispensing. If you are considering community pharmacy as a career path, or if you are weighing up where you want to work after registration, understanding what the sector is fighting for — and why — gives you a more grounded picture of what that career might look like.
Beba's comments also reflect something worth paying attention to as a professional: pharmacists advocating clearly and publicly for an expanded scope isn't just lobbying. It's part of how the profession makes the case for its own value. That kind of advocacy, whether through professional bodies, the media, or local NHS partnerships, is increasingly part of what it means to be a senior pharmacist.
GPhC exam relevance
The GPhC Common Registration Assessment tests applied clinical knowledge rather than current affairs, but the themes in this story connect to areas that appear in the assessment.
Obesity as a condition sits within long-term condition management, and you should be comfortable with the general principles of treatment: lifestyle modification as a first-line approach, the role of pharmacotherapy, and the criteria that guide prescribing decisions. You don't need to know the detail of every commissioning arrangement or service framework, but understanding how medications used in weight management work — their mechanisms, monitoring requirements, and common interactions — is fair game.
More broadly, the assessment tests whether you understand the pharmacist's role within the wider health system. Questions about when to refer, how to support patients with long-term conditions, and how to communicate treatment options clearly all draw on exactly the kind of clinical reasoning Beba's comments point to. Community pharmacy's push for a greater role in obesity care assumes that pharmacists are competent to carry out that work safely. The exam is partly testing whether you are.
Service design questions are less common at foundation level, but being able to articulate what community pharmacy can and can't do — and why — is useful context for any viva or structured discussion in your training year.
What's next
The call from pharmacists like Beba for a bigger role in obesity care will only gain traction if it's backed by commissioning decisions, funding agreements, and clear service specifications. Watch for any NHS England announcements on weight management pathways that include community pharmacy, and pay attention to how professional bodies like the Royal Pharmaceutical Society frame pharmacy's place in obesity prevention over the coming months.
If you are in your training year, it's worth asking your designated supervisor whether your site is involved in any weight management services or whether there have been local conversations about commissioning. Seeing how these discussions play out at the practice level gives you a much more concrete understanding of how professional advocacy translates — or doesn't — into actual services.
Source: Chemist+Druggist — https://www.chemistanddruggist.co.uk/news/clinical/community-pharmacies-very-keen-to-have-greater-role-in-obesity-care-CSOJ2KV53RBDFMZF6CQZWC5G7Q/